Seres Therapeutics (MCRB) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

MCRB is expected to report earnings to fall 67.41% to -7 cents per share on November 06

Seres Therapeutics MCRB Stock Earnings Reports

Q3'24

Est.

$-0.07

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.07

Q4'23

Beat

by $0.19

Q3'23

Beat

by $0.13

The last earnings report on August 13 showed earnings per share of -21 cents, beating the estimate of -27 cents. With 24.94M shares outstanding, the current market capitalization sits at 137.14M.

View a ticker or compare two or three

Compare

MCRB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MCRB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel treatments for diseases related to the human microbiome

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

101 Cambridgepark Drive

Phone

+1 617 945-9626

Employees

233

Web

https://www.serestherapeutics.com